TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27414470

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT) delivered by lay counselors
Number of subjects: 12
Study: 26331348

Group type: EXPERIMENTAL
Intervention: Plerixafor (240 mg/kg subcutaneously) in combination with G-CSF (5 mg/kg/day increasing to 10 mg/kg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: G-CSF alone (without plerixafor)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Plerixafor (240 mg/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Plerixafor and G-CSF
Number of subjects: 45
Study: 24165214

Group type: EXPERIMENTAL
Intervention: Event History Calendar (EHC)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Guidelines for Adolescent Preventive Services (GAPS)
Number of subjects: 186
Study: 20817283

Group type: EXPERIMENTAL
Intervention: Intracoronary (IC) abciximab administration
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard intravenous (IV) abciximab administration
Number of subjects: 154
Study: 19363853

Group type: EXPERIMENTAL
Intervention: NB‐UVB + LCD therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: NB‐UVB alone
Number of subjects: 0
Study: 16429087

Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 52

Group type: COMPARATOR
Intervention: No stimulant medication (comparison group)
Number of subjects: 52
Study: 15238567

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (16 mg once daily)
Number of subjects: 809

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 809
Study: 11710664

Group type: EXPERIMENTAL
Intervention: High-resistance training (70-90% 1RM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-resistance training (40-60% 1RM)
Number of subjects: 30
Study: 9681307

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.2 mg/kg oral midazolam
Number of subjects: 50
Study: 8023667

Group type: EXPERIMENTAL
Intervention: Preoperative infiltration of the surgical area with bupivacaine 0.25%, 40 ml (group I)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No infiltration (group II)
Number of subjects: 49
Study: 2641954

Group type: EXPERIMENTAL
Intervention: 0.2% NaF solution
Number of subjects: 295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study: 4460068

Group type: EXPERIMENTAL
Intervention: 12 ounces (360 ml) of 95 proof ethanol (133.68 g ethanol)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Non availability of ethanol
Number of subjects: 5
Study: 31486196

Group type: EXPERIMENTAL
Intervention: Plantain syrup and placebo capsule
Number of subjects: 68

Group type: COMPARATOR
Intervention: Mefenamic acid capsule and placebo syrup
Number of subjects: 68
Study: 31562509

Group type: EXPERIMENTAL
Intervention: Novel meal detection algorithm using CGM data
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Real-world data analysis of meal detection
Number of subjects: 30
Study: 28483402

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg daily for 7 days, 200 mg on the first day)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 305
Study: 26272281

Group type: EXPERIMENTAL
Intervention: S0597 at 200 μg/d
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: S0597 at 400 μg/d
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: S0597 at 800 μg/d
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: S0597 (all doses)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 23736782

Group type: EXPERIMENTAL
Intervention: Intraset rest intervals (ISR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional rest (TRD)
Number of subjects: 22
Study: 21658839

Group type: EXPERIMENTAL
Intervention: GreenLight HPS 120-W laser PVP
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 50
Study: 17935216

Group type: EXPERIMENTAL
Intervention: Acute stress disorder (ASD) participants
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non‐traumatized controls
Number of subjects: 25
Study: 16434506

Group type: EXPERIMENTAL
Intervention: SRL‐ST (Sirolimus therapy after CsA withdrawal)
Number of subjects: 430

Group type: COMPARATOR
Intervention: SRL‐CsA‐ST (Sirolimus with Cyclosporine and steroids)
Number of subjects: 430
Study: 12091818

Group type: EXPERIMENTAL
Intervention: Minimally invasive coronary artery bypass grafting (surgical intervention)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty with primary stenting (stenting)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 102
Study: 10048612

Group type: EXPERIMENTAL
Intervention: Single application of triple dye
Number of subjects: 180

Group type: COMPARATOR
Intervention: Multiple applications of triple dye
Number of subjects: 180
Study: 7734350

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy for AML with a monoblastic component
Number of subjects: 86
Study: 2073671

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg nightly (n = 17)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Gemfibrozil 600 mg twice daily (n = 8)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg nightly (n = 23)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Gemfibrozil 600 mg b.i.d. (n = 19)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Gemfibrozil
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 67
Study: 6105721

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 6333649

Group type: EXPERIMENTAL
Intervention: High dose methylprednisolone sodium succinate (30 mg/kg q6h X2, then 250 mg q6h X6, then tapering over 8 days)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low dose methylprednisolone (1.5 mg/kg q6h X2, then 25 mg q6h X6, then tapering over 8 days)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High dose methylprednisolone sodium succinate
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low dose methylprednisolone and placebo
Number of subjects: 88
Study: 31132584

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 12

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 12
Study: 28840969

Group type: EXPERIMENTAL
Intervention: Intraprostatic botulinum toxin type A injection (200-300 UI in 6-8 mL saline)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline solution (SS)
Number of subjects: 20
Study: 27661432

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide (ILTA) with carbon dioxide laser
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide (ILTA) with cryotherapy
Number of subjects: 60
Study: 24726027

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET) for 12 sessions
Number of subjects: 34

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 34
Study: 22329608

Group type: EXPERIMENTAL
Intervention: BUD/FM pMDI 160/9 μg bid
Number of subjects: 1028

Group type: COMPARATOR
Intervention: BUD pMDI 160 μg bid
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: BUD/FM pMDI 320/9 μg bid
Number of subjects: 1028

Group type: COMPARATOR
Intervention: BUD pMDI 320 μg bid
Number of subjects: 1028

Group type: COMPARATOR
Intervention: BUD dry powder inhaler 360 μg bid
Number of subjects: 1028
Study: 19841982

Group type: EXPERIMENTAL
Intervention: Immediate microsurgical free flap reconstruction
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Immediate microsurgical free flap reconstruction (randomized matched-pair analysis)
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Extent of tumor (T3 and T4)
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Extent of tumor (T1 and T2)
Number of subjects: 773
Study: 17644330

Group type: EXPERIMENTAL
Intervention: Radiotherapy and tamoxifen 30 mg/day for one year (RT+tam)
Number of subjects: 724

Group type: COMPARATOR
Intervention: Tamoxifen (tam)
Number of subjects: 724

Group type: COMPARATOR
Intervention: Radiotherapy 50 Gy/25 fractions to chest wall and regional lymph nodes (RT)
Number of subjects: 724
Study: 16096179

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1% applied four times daily (QID)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Pimecrolimus cream 1% applied twice daily (BID)
Number of subjects: 49
Study: 11792138

Group type: EXPERIMENTAL
Intervention: First day angiography/angioplasty
Number of subjects: 131

Group type: COMPARATOR
Intervention: Early conservative therapy
Number of subjects: 131
Study: 10521814

Group type: EXPERIMENTAL
Intervention: Maternal urine beta-core human chorionic gonadotrophin (hCG) screening
Number of subjects: 6730
Study: 7738628

Group type: EXPERIMENTAL
Intervention: Granisetron 10 micrograms/kg
Number of subjects: 987

Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms/kg
Number of subjects: 987

Group type: COMPARATOR
Intervention: Ondansetron 0.15 mg/kg
Number of subjects: 987
Study: 2187948

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 687

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 687
Study: 7031085

Group type: EXPERIMENTAL
Intervention: Triton X-100 SPV
Number of subjects: 76

Group type: COMPARATOR
Intervention: Tween-ether SPV
Number of subjects: 76
Study: 30243839

Group type: EXPERIMENTAL
Intervention: Oxymetazoline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30217943

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) inhalation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sterilized water (control)
Number of subjects: 60
Study: 26762125

Group type: EXPERIMENTAL
Intervention: Facilitation of community groups with high-rated facilitators (n=27)
Number of subjects: 1508

Group type: COMPARATOR
Intervention: Control communes (n=46)
Number of subjects: 1508
Study: 24566755

Group type: EXPERIMENTAL
Intervention: Fetal fibronectin (FFN)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Cervical length ≤ 25 mm
Number of subjects: 214

Group type: COMPARATOR
Intervention: 17-hydroxyprogesterone caproate (17OHPc)
Number of subjects: 214
Study: 22894939

Group type: EXPERIMENTAL
Intervention: Total HMOs above the median (1.87 g/L)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Lacto-N-neotetraose concentrations
Number of subjects: 203

Group type: COMPARATOR
Intervention: 3'-sialyllactose (3'-SL) per total HMOs
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Non-3'-SL HMOs
Number of subjects: 203
Study: 20655106

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (5 parts per million)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo gas (nitrogen gas)
Number of subjects: 800
Study: 17559369

Group type: EXPERIMENTAL
Intervention: Dioctahedral smectite (DS), 3 sachets daily for 8 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: COMPARATOR
Intervention: Dioctahedral smectite (DS) and Placebo
Number of subjects: 104
Study: 16236851

Group type: EXPERIMENTAL
Intervention: High-intensity cycle ergometer exercise training program for 45 min, three times a week for 7 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-intensity cycle ergometer exercise training
Number of subjects: 24
Study: 11863328

Group type: EXPERIMENTAL
Intervention: Shunting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patching
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-operative EEG monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type of anaesthetic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-operative anticoagulation (not used)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Operation time <1 h or >1.5 h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgeons' subjective assessment of operation difficulty
Number of subjects: 0
Study: 10612566

Group type: COMPARATOR
Intervention: Vbeta2 gene expression in BALF
Number of subjects: 17

Group type: COMPARATOR
Intervention: Vbeta6 gene expression in BALF
Number of subjects: 17

Group type: COMPARATOR
Intervention: Vbeta2 gene overexpression in BALF samples
Number of subjects: 17

Group type: COMPARATOR
Intervention: Vbeta6 gene overexpression in BALF samples
Number of subjects: 17
Study: 7717715

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-granisetron
Number of subjects: 40
Study: 1674963

Group type: EXPERIMENTAL
Intervention: Gastric lavage
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ipecacuanha-induced emesis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 6800003

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prazepam
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31957527

Group type: EXPERIMENTAL
Intervention: Leflunomide (LEF) combined with prednisone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cyclophosphamide (CTX) combined with prednisone
Number of subjects: 60
Study: 30518130

Group type: EXPERIMENTAL
Intervention: Whey protein supplement (0.4 g protein/kg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 29
Study: 26286012

Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles injected beneath the lesion sites 3 cm
Number of subjects: 24

Group type: COMPARATOR
Intervention: No treatment with carbon nanoparticles (Control Group B)
Number of subjects: 24
Study: 25617572

Group type: EXPERIMENTAL
Intervention: Exergaming platform (Wii-Fit)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treadmill walking
Number of subjects: 42
Study: 23286611

Group type: EXPERIMENTAL
Intervention: Management informatics system intervention for mammography screening
Number of subjects: 32688
Study: 21085810

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate (CHX) rinsing for 21 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (plaque-free surfaces)
Number of subjects: 20
Study: 17628971

Group type: EXPERIMENTAL
Intervention: Endoscopic sinus surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 120
Study: 16327031

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (400 mg alpha‐lipoic acid, 200 mg co‐enzyme Q10, 12 mg manganese, 600 mg vitamin C, 800 mg N‐acetyl cysteine, 400 microg selenium, and 400 IU alpha‐tocopherol per day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11998383

Group type: EXPERIMENTAL
Intervention: Perfluothane
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment with perfluothane (Control)
Number of subjects: 40
Study: 9714109

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cigarette smoking with nitroprusside
Number of subjects: 19
Study: 7985708

Group type: EXPERIMENTAL
Intervention: Dietary fiber (20 g/day) administered twice a day for 36 weeks
Number of subjects: 59
Study: 2519943

Group type: EXPERIMENTAL
Intervention: Potassium chloride (KCl) 12 mmol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Potassium-magnesium-aspartate (KMA) 12 mmol
Number of subjects: 20
Study: 30106535

Group type: EXPERIMENTAL
Intervention: 30 mg codeine + 500 mg paracetamol (CP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen (IB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 400 mg placebo (PL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide bleaching
Number of subjects: 60
Study: 27799178

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 mg perineurally with ropivacaine 0.5%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ropivacaine 0.5% alone (saline control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 mg perineurally
Number of subjects: 20
Study: 25440795

Group type: EXPERIMENTAL
Intervention: Platelet function monitoring with dose and drug adjustment (Prasugrel 5 mg)
Number of subjects: 852

Group type: COMPARATOR
Intervention: Conventional Treatment Arm (Prasugrel 5 mg without monitoring and adjustment)
Number of subjects: 852
Study: 22805468

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (280 mg DHA and 110 mg EPA daily)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control oil
Number of subjects: 420
Study: 21187503

Group type: EXPERIMENTAL
Intervention: IT+MGN-3 (38 patients)
Number of subjects: 68

Group type: COMPARATOR
Intervention: IT (30 patients)
Number of subjects: 68
Study: 18270233

Group type: EXPERIMENTAL
Intervention: Water-induced wrinkling
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: EMLA-induced wrinkling
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intraepidermal nerve fibre density (IENFD)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sympathetic skin response (SSR)
Number of subjects: 21
Study: 15686572

Group type: EXPERIMENTAL
Intervention: Gesture conveying a different strategy than speech
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Two problem-solving strategies taught in gesture
Number of subjects: 160

Group type: COMPARATOR
Intervention: Gesture conveying the same strategy as speech
Number of subjects: 160
Study: 14682412

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate DPI 250 microg b.i.d.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 10776899

Group type: EXPERIMENTAL
Intervention: Continuous hypoxia
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both continuous and intermittent hypoxia
Number of subjects: 10
Study: 8640993

Group type: EXPERIMENTAL
Intervention: MR cine GE images
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard MR SE images
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combined analysis of SE and GE images
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: MR phase velocity imaging
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Sequential grafts
Number of subjects: 47
Study: 8261256

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2890501

Group type: EXPERIMENTAL
Intervention: Insulin plus glyburide (IG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Insulin plus placebo (IP)
Number of subjects: 20
Study: 31801787

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 2536
Study: 29390162

Group type: EXPERIMENTAL
Intervention: Androstadienone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 30
Study: 28265777

Group type: EXPERIMENTAL
Intervention: ISB + ICG (n = 180)
Number of subjects: 200

Group type: COMPARATOR
Intervention: ISB (n = 20)
Number of subjects: 200
Study: 26509769

Group type: EXPERIMENTAL
Intervention: Carbomer-based lipid-containing artificial tear formulations (CBLAT) in the add-on group
Number of subjects: 412

Group type: COMPARATOR
Intervention: Carbomer-based lipid-containing artificial tear formulations (CBLAT) in the switching group
Number of subjects: 412
Study: 23194385

Group type: EXPERIMENTAL
Intervention: Intervention (sustained nurse home visiting)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 208
Study: 21508278

Group type: EXPERIMENTAL
Intervention: Highly cross‐linked polyethylene
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional ultra‐high molecular weight polyethylene
Number of subjects: 54
Study: 19788662

Group type: EXPERIMENTAL
Intervention: 2.2 mm incision
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 2.6 mm incision
Number of subjects: 83

Group type: COMPARATOR
Intervention: 3.0 mm incision
Number of subjects: 83
Study: 16449487

Group type: EXPERIMENTAL
Intervention: Second-generation antidepressants adjunctive to mood stabilizers
Number of subjects: 184

Group type: COMPARATOR
Intervention: Mood stabilizers
Number of subjects: 184
Study: 15310534

Group type: EXPERIMENTAL
Intervention: Combination hormone therapy (conjugated equine estrogen, 0.625 mg, and medroxyprogesterone, 2.5 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11273921

Group type: EXPERIMENTAL
Intervention: Low sensory stimulation group (LSSG) with dimmed OR lights (200 Lx) and soft background music (Bach's 'Air on a G String', 50‐60 dB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (standard operating conditions)
Number of subjects: 70
Study: 8813502

Group type: EXPERIMENTAL
Intervention: Retrograde laparoscopic cholecystectomy (RLC)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy
Number of subjects: 173
Study: 1864667

Group type: EXPERIMENTAL
Intervention: Prenalterol (35 micrograms/kg for 3 min)
Number of subjects: 21

Group type: COMPARATOR
Intervention: K-strophanthidin (0.008 mg/kg for 5-10 min)
Number of subjects: 21
Study: 6843182

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0
Study: 31833801

Group type: EXPERIMENTAL
Intervention: SAR341402 (SAR-Asp)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Originator insulin aspart (NN-Asp)
Number of subjects: 45
Study: 30565797

Group type: EXPERIMENTAL
Intervention: Maternal role training program based on Mercer's Maternal Role Attainment Theory
Number of subjects: 67

Group type: COMPARATOR
Intervention: Routine pregnancy care (Control)
Number of subjects: 67
Study: 27684440

Group type: EXPERIMENTAL
Intervention: ADT + metformin
Number of subjects: 62

Group type: COMPARATOR
Intervention: ADT
Number of subjects: 62
Study: 26308457

Group type: EXPERIMENTAL
Intervention: Integrated Psychological Intervention (IPI), including psychoeducation
Number of subjects: 128

Group type: COMPARATOR
Intervention: Supportive Counselling (SC)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Integrated Psychological Intervention (IPI)
Number of subjects: 128
Study: 22752014

Group type: EXPERIMENTAL
Intervention: Preoperative CISC instructional video
Number of subjects: 199

Group type: COMPARATOR
Intervention: Routine counseling
Number of subjects: 199
Study: 22059392

Group type: EXPERIMENTAL
Intervention: EMA-14 (Esomeprazole 20 mg b.i.d., Moxifloxacin 400 mg o.d., Amoxicillin 1000 mg b.i.d. for 14 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: EMA-7 (Esomeprazole 20 mg b.i.d., Moxifloxacin 400 mg o.d., Amoxicillin 1000 mg b.i.d. for 7 days)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: EMA-14
Number of subjects: 80

Group type: COMPARATOR
Intervention: EMA-7
Number of subjects: 80